Analgesics (Pharmacies) - Southern Asia

  • Southern Asia
  • Revenue in the Analgesics market is projected to reach US$1.35bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 8.82%, resulting in a market volume of US$2.06bn by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.70 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Southern Asia is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of this market. Customer preferences in Southern Asia play a crucial role in the growth of the Analgesics (Pharmacies) market. Consumers in this region have shown a growing preference for over-the-counter pain relief medications, such as analgesics, due to their convenience and accessibility. With busy lifestyles and a desire for immediate relief, consumers are increasingly turning to pharmacies to purchase these products. This preference for convenience is driving the demand for analgesics in Southern Asia. Trends in the market further support the growth of the Analgesics (Pharmacies) market in Southern Asia. One notable trend is the increasing prevalence of chronic pain conditions, such as arthritis and back pain, among the population. As the population ages and lifestyles become more sedentary, the demand for pain relief medication is expected to rise. This trend is driving the growth of the analgesics market in the region. Another trend in the market is the growing popularity of natural and herbal analgesics. Consumers are becoming more conscious of the potential side effects of traditional analgesics and are seeking alternative options. This trend is particularly prominent in Southern Asia, where traditional medicine practices have a long history. The demand for natural and herbal analgesics is driving the growth of this segment in the market. Local special circumstances also contribute to the development of the Analgesics (Pharmacies) market in Southern Asia. One such circumstance is the increasing urbanization in the region. As more people migrate to cities and urban areas, the demand for healthcare services, including pharmacies, is on the rise. Pharmacies are becoming an essential part of the healthcare infrastructure in these urban areas, leading to increased sales of analgesics. Underlying macroeconomic factors also play a role in the growth of the Analgesics (Pharmacies) market in Southern Asia. The region is experiencing steady economic growth, which has led to an increase in disposable income. As people have more money to spend, they are more likely to purchase analgesics for pain relief. Additionally, the growing middle class in Southern Asia has contributed to the expansion of the market, as this demographic segment has more purchasing power and is willing to spend on healthcare products. In conclusion, the Analgesics (Pharmacies) market in Southern Asia is developing at a rapid pace due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The convenience of over-the-counter analgesics, the increasing prevalence of chronic pain conditions, the popularity of natural and herbal options, urbanization, and economic growth all contribute to the positive trajectory of this market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)